No Data
No Data
MercadoLibre Posts Upbeat Results, Joins Integral Ad Science, Willdan Group, Fresh Del Monte Produce And Other Big Stocks Moving Higher On Friday
Craig-Hallum Maintains Cerus(CERS.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Takeda Pharmaceutical Co (OtherTKPHF), Cerus (CERS) and Ultragenyx Pharmaceutical (RARE)
Stifel Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $6
TD Cowen Maintains Cerus(CERS.US) With Buy Rating, Maintains Target Price $5
Cerus Corporation: A Strong Buy on Robust Revenue Growth and Market Expansion
No Data